These side effects can then lead to dehydration and nutrient deficiencies, which, in turn, may pave the way for other issues like hair loss or fatigue
On 1 April 2026, the FDA approved Foundayo (orforglipron) for adults with obesity or overweight with weight-related medical conditions, making it the first small-molecule oral GLP-1 receptor agonist to receive regulatory clearance anywhere in the world
Intramuscular B12 shots can sting quite a bit, which is unfortunate, because it discourages some people from self-injecting
Pregnancy presents a unique challenge in APD because progesterone levels rise steadily and remain elevated throughout gestation
Frequency of hospitalization after exposure to known drug-drug interactions in a Medicaid population
This guide does not deal in generalities